16h55 - 17h20 -
Dr Marc Cerou (SANOFI Paris)
- A novel drug-disease model in oncology for benefit-risk evaluation of antibody drug conjugates: application to tusamitamab ravtansine monotherapy 17h20 - 17h45 -
Dr Anne Rodallec (INSERM Univ Aix Marseille)
- Model-driven optimization of the scheduling of a novel anti-cancer prodrug administered subcutaneously
17h45 - 17h50 Day wrap-up 18h00 - Drinks and food at each person own expenses at the Hotel Maison Montmartre rooftop